Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Neither compound should be considered a licensed medicine in the UK, and both require careful scrutiny before any consideration of use
Contact Us Get in touch with Beacon Pharmacy for friendly advice, healthcare support, and appointment bookings from our experienced team
This makes it the cleanest GHRP to pair with CJC-1295, and explains why clinics favor it over the alternatives
& Frye, R
Experience the transformative effects of our Microneedling service, a minimally invasive procedure that stimulates the skins natural collagen and elastin production
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
US$ 20.41
US$ 22.66
US$ 26.86
US$ 28.83
US$ 20.85
US$ 20.35
US$ 24.29
